Cancer institute's drug program reproved.
D030881:Disclosure; D004341:Drug Evaluation / Q000592:standards*; D035082:Federal Government; D033161:Government Regulation; D006801:Humans; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000188:drug therapy*; D011057:Politics; D018570:Risk Assessment; D036302:Therapeutic Human Experimentation; D014481:United States; D014486:United States Food and Drug Administration